OFAC sanctioned the Argentina-based Goldpharma Drug
Trafficking and Money Laundering Organization ("Goldpharma
DTO/MLO"), identifying the entity as a "significant
foreign narcotics trafficker" pursuant to the
Foreign Narcotics Kingpin Designation Act. OFAC also designated
eight Argentine nationals for their role in the Goldpharma DTO/MLO,
along with nine entities in Argentina, Colombia, Canada, the United
Kingdom and the Netherlands.
According to OFAC, Goldpharma DTO/MLO operates a network of
online pharmacy websites, which sell narcotics to customers without
a prescription. OFAC asserted that Goldpharma DTO/MLO sells the
majority of its illicit opioids to customers located in the
U.S.
